-
Mashup Score: 0
This report summarizes all fellowship Matches in the NRMP’s Specialties Matching Service® (SMS®). Data are provided for Matches conducted in 2024 and early 2025 for appointments beginning July 2025.
Source: www.nrmp.orgCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 1Association between rheumatoid arthritis and interstitial lung disease and impact of serologic status: a large-scale longitudinal study - 5 day(s) ago
Scientific Reports – Association between rheumatoid arthritis and interstitial lung disease and impact of serologic status: a large-scale longitudinal study
Source: www.nature.comCategories: General Medicine News, General HCPsTweet-
8 fold risk of incident ILD in #RA pts. Data from Korean National Health Insurance, 52,325 RA pts & 261,625 controls & 4.4 yrs F/U - ILD in 3.7% of RA vs 0.5% controls (adjHR 7.84); higher in seropositive RA (aHR= 9) vs seronegative RA (aHR=4.8) https://t.co/iIoZOwFYEN https://t.co/HBzSg9KrpZ
-
-
Mashup Score: 2Corticosteroid use in PFAPA syndrome: clinical practice data from the JIR-CliPS Survey Study and a comprehensive literature review - 5 day(s) ago
AbstractObjectives. CS are used to abort disease flares in periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome. We aime
Source: academic.oup.comCategories: General Medicine News, General HCPsTweet-
Survey on Corticosteroid (CS) use in PFAPA syndrome included 144 MDs (67% pedi-Rheums); 92% use CS in PFAPA flares. 42% expected a response w/in 12 hrs. 31% use CS ‘routinely. Med literature cites Prednisone as most preferred CS (48%). Response to CS ~ 95% https://t.co/V1wkhNaNAP https://t.co/YILAlKrUcQ
-
-
Mashup Score: 2Lupus Flares: More Common in Dialysis Patients than in Post‐Kidney Transplant Recipients ‐ A Systematic Review and Meta‐Analysis - 5 day(s) ago
Objectives In this study, we performed a systematic literature review and meta-analysis to assess the frequency of Systemic Lupus Erythematosus (SLE) flares in patients with ESRD and patients underg…
Categories: General Medicine News, General HCPsTweet-
Lupus flares after ESRD? Metanalysis of 34 studies (29 on HD/PD; 5 post transplant/KT) - extra-renal flares seen in 36% of ESRD pts & were significantly higher w/ PD/HD vs KT (OR: 4.36; 1.66-11.47, p=0.0028). Recurrence of LN after KT was 3.4% https://t.co/tXlyxsfvXd https://t.co/tzsMCeRkz4
-
-
Mashup Score: 1EGPA in 2025 | RheumNow - 5 day(s) ago
Formerly classified as an ANCA-associated vasculitis, EGPA is both most commonly ANCA negative and clinically different to the other two ANCA-associated vasculitis conditions, GPA and MPA. The management of EGPA has frequently fallen into the trap of being copied from its more common and well-known cousins. Now, however, we are seeing a discordance and following GPA/MPA management will potentially lead to both over-treatment and suboptimal treatment for EGPA. In this context, the Sunday morning session at RNL 2025 on “EGPA management in 2025 and beyond” by Dr. Michael Wechsler was both timely and clinically relevant.
Source: rheumnow.comCategories: General Medicine News, General HCPsTweet-
EGPA in 2025 Eosinophilic Granulomatosis with Polyangiitis (EGPA), the artist formerly known as Churg-Strauss syndrome, remains somewhat of a rogue agent among the vasculitides. https://t.co/4ofjQRYsMH https://t.co/PoVhaQ9QiZ
-
-
Mashup Score: 0
Traditionally, rheumatologists have often been deferential to the non-articular concerns in RA to other providers, though these issues are often left unaddressed. What role do rheumatologists have in the management of multimorbidity in our patients?
Source: rheumnow.comCategories: General Medicine News, General HCPsTweet-
That's not my problem - or is it? Multimorbidity in RA RA can look so easy on the television commercials where patients appear young, healthy, and vibrant on the advertised treatment. https://t.co/B7WUiysNSE https://t.co/nczmoIBfOb
-
-
Mashup Score: 25Obinutuzumab Efficacy in Active Lupus Nephritis | RheumNow - 10 day(s) ago
A phase 3, randomized controlled trial of an anti-CD20 monoclonal antibody, obinutuzumab, was shown to be effective and safe in patients with active lupus nephritis.
Source: rheumnow.comCategories: General Medicine News, General HCPsTweet-
Obinutuzumab Efficacy in Active Lupus Nephritis A phase 3, randomized controlled trial of an anti-CD20 monoclonal antibody, obinutuzumab, was shown to be effective and safe in patients with active lupus nephritis. https://t.co/e1cDvJcC9g https://t.co/HUDd1ocAvc
-
-
Mashup Score: 9Drug Naming Games (2.7.2025) | RheumNow - 11 day(s) ago
Dr. Jack Cush reviews the news, regulatory and journal reports from the past week on RheumNow.com.
Source: rheumnow.comCategories: General Medicine News, General HCPsTweet-
Drug Naming Games (2.7.2025) Dr. Jack Cush reviews the news, regulatory and journal reports from the past week on RheumNow. https://t.co/3VV9aBCTzd https://t.co/1xYuVHt802
-
-
Mashup Score: 1Cannabis Hospitalizations and Mortality Risk | RheumNow - 12 day(s) ago
A Canadian population, retrospective cohort study shows individuals needing hospital-based (emergency department or hospitalization) care for a cannabis use disorder (CUD) were at increased risk of death. Cannabis use disorders (CUD) are associated with adverse health effects, including mental disorders and motor vehicle collision-related injuries. However, little is known about whether CUDs are associated with increased mortality risk.
Source: rheumnow.comCategories: General Medicine News, RheumatologyTweet-
Cannabis Hospitalizations and Mortality Risk A Canadian population, retrospective cohort study shows individuals needing hospital-based (emergency department or hospitalization) care for a cannabis use disorder (CUD) were at increased risk of death. https://t.co/MQtR3etpEH https://t.co/ZB4byi81on
-
-
Mashup Score: 21'If Boundaries Are Set, It Is Possible': Medscape Physician Mental Health & Well-Being Report 2025 - 13 day(s) ago
Physicians discuss whether their personal lives are improving, if there is time to attend to their own wellness, and if balance is possible in their profession.
Source: www.medscape.comCategories: General Medicine News, General HCPsTweet-
How did Rheumatology go from being the happiest specialist to now being 5th from the bottom at 65%? Top heavy happiness seems to be influenced by income? what do you think? Allergy 94% Pathology 88% Dermatology 87% .... Rheum 67% Internal med 66%... https://t.co/2KazmCbX39 https://t.co/LgZ8KJPMet
-
NRMP Publishes 2025 Match Results. Rheumatology Stats: - Ped Rheum #5 in # U.S. DO grads (30%) - Adult Rheum #5 in Intl Med school grads (34%) - Adult: 3/132 progr. went unfilled (Ped: 20/36 unfilled) https://t.co/AsfOZMydMK https://t.co/Dim3hCLzXC